Editors' Pick No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine. Pakpoor J, Disanto G, Altmann DR, Pavitt S, Turner BP, Marta M, Juliusson G, Baker D, Chataway J, Schmierer K Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2(6):e158. Epub 2015 Oct 01. PMID: 26468472. Abstract CommentRecommendBookmarkWatch